CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Laboratorios Farmaceuticos Rovi S.A. Company Snapshot
Laboratorios Farmaceuticos Rovi S.A. operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Laboratorios Farmaceuticos Rovi S.A. with three other pharmaceutical manufacturers in Europe: Valneva SE of France (2016 sales of 94.06 million Euro [US$105.69 million] of which 86% was Commercialized Vaccines), Eczacibasi Ilac Sanayi ve T.A.S. of Turkey (1.41 billion Turkish Liras [US$396.90 million] of which 74% was Personal Care), and Abcam PLC which is based in the United Kingdom (£171.67 million [US$223.24 million] of which 100% was Antibodies & Related Products).

Sales Analysis. During the year ended December of 2016, sales at Laboratorios Farmaceuticos Rovi S.A. were 265.17 million Euro (US$297.94 million). This is an increase of 7.8% versus 2015, when the company's sales were 246.01 million Euro. This was the fifth consecutive year of sales increases at Laboratorios Farmaceuticos Rovi S.A. (and since 2011, sales have increased a total of 44%). Sales of Marketing saw an increase of 15.3% in 2016, from 201.92 million Euro to 232.79 million Euro. Not all segments of Laboratorios Farmaceuticos Rovi S.A. experienced an increase in sales in 2016: sales of Production fell 3.8% to 110.88 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Laboratorios Farmaceuticos Rovi S.A.
  Stock Performance Chart for Laboratorios Farmaceuticos Rovi S.A.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 15.68
(Figures in Euro)
1 Week 2.0%   13 Weeks 6.7%  
4 Weeks 8.6%   52 Weeks 12.0%  
 
Laboratorios Farmaceuticos Rovi S.A. Key Data:
  Ticker: ROVI Country: Spain
  Exchanges: MAD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 265,166,000
(Year Ending Jan 2017).
Employees: 1,150
  Currency: Euro Market Cap: 772,748,879
  Fiscal Yr Ends: December Shares Outstanding: 49,282,454
  Share Type: Accion Closely Held Shares: 37,320,156
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.